Yields of dual therapy containing high-dose proton pump inhibitor in eradication of H. Pylori positive dyspeptic patients

Hepato-Gastroenterology

Volumn 61, Issue 133, 2014, Pages 1454-1458

  Ince, Ali Tüzün ^a   Tozlu, Mukaddes ^a   Baysal, Birol ^a   Şentürk, Hakan ^a   Arici, Sema ^a   Oz̈den, Ali ^b  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Dual therapy; Dyspepsia; H. Pylori; HpSA; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LARGOPEN; OMEPRAZOLE; PROSEK; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BLOATING; CHRONIC GASTRITIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DRUG MEGADOSE; DUODENUM ULCER; DYSPEPSIA; EPIGASTRIC BURNING; EPIGASTRIC PAIN; ERADICATION THERAPY; ESOPHAGITIS; FEMALE; HEALTH CARE QUALITY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SATIETY; SMOKING HABIT; STOMACH ULCER; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG COST; DRUG EFFECTS; ECONOMICS; GROWTH, DEVELOPMENT AND AGING; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906972360     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge14372     Document Type: Article

References (26)

1. Lacy BE, Talley NJ, Locke GR 3rd, et al.: Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 2012; 36: 3-15.
2. Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-1679.
3. McNamara D, Buckley M, Gilvarry J, et al.: Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: A 5-year follow-up study. Helicobacter 2002; 7:317-321. (Pubitemid 35229931)
4. Froehlich F, Gonvers JJ, Wietlisbach V, et al.: Eradication in Dyspepsia (ERADYS) Study Group. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol 2001; 96: 2329-2336. (Pubitemid 32769191)
5. Malfertheiner P, Sipponen P, Naumann M, et al.: H. pylori-Gastric Cancer Task Force. Helicobacterpylori eradication has the potential to prevent gastric cancer: A state-of-the-art critique. Am J Gastroenterol 2005; 100: 2100-2115.
6. el-Zimaity HM.: Accurate diagnosis of Helicobacter pylori with biopsy. Gastroenterol Clin N Am 2000; 29: 863-869.
7. Midolo P, Marshall BJ.: Accurate diagnosis of Helicobacter pylori. Urease tests. Gastroenterol Clin N Am 2000; 29: 871-878. (Pubitemid 32466729)
8. Perna F, Ricci C, Gatta L, et al.: Diagnostic accuracy of a new rapid urease test (Pronto Dry), before and after treatment of Helicobacter pylori infection. Minerva Gastroenterol Dietol 2005; 51: 247-254. (Pubitemid 41739898)
9. Ahmed F, Chey WD, Murthy U, et al.: Evaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication. Aliment Pharmacol Ther 2005; 22: 875-880. (Pubitemid 41564368)
10. Chey WD, Wong BC.: Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102: 1808-1825. (Pubitemid 47206706)
11. Gisbert JP, Pajares JM.: Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review. Aliment Pharmacol Ther 2004; 20:1001-10017.
12. Chey WD.: Accurate diagnosis of Helicobacter pylori. 14C-urea breath test. Gastroenterol Clin N Am 2000; 29: 895-902.
13. Katelaris PH, Forbes GM, Talley NJ, et al.: A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study. Gastroenterology 2002; 123:1763-1769. (Pubitemid 35408299)
14. Gen'e E, Calvet X, Azagra R, et al.: Triple vs. Quadruple therapy for treating Helicobacter pylori infection: A metaanalysis. Aliment Pharmacol Ther 2003; 17: 1137-1143. (Pubitemid 36605750)
15. Malfertheiner P, Megraud F, O'Morain CA, et al.: European Helicobacter Study Group. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut. 2012; 61: 646-664.
16. Duck WM, Sobel J, Pruckler JM, et al.: Antimicrobial resistance incidence and risk factors among Helicobacterpylori-infected persons, United States. Emerg Infect Dis 2004; 10: 1088-1094. (Pubitemid 38697703)
17. Shirai N, Sugimoto M, Kodaira C, et al.: Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. Eur J Clin Pharmacol 2007; 63: 743-749. (Pubitemid 47052044)
18. Celebi A, Kocaman O, Savli H, et al.: The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia. Turk J Gastroenterol. 2009; 20: 161-164.
19. Villoria A, Garcia P, Calvet X, et al.: Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2008; 28: 868-877.
20. Isomoto H, Inoue K, Furusu H, et al.: High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Aliment Pharmacol Ther. 2003; 18: 101-107. (Pubitemid 36897986)
21. Hunt RH, Xiao SD, Megraud F, et al.: World Gastroenterology Organisation Global Guidelines: Helicobacter pylori in developing countries. World Gastroenterology Organisation, August 2010. p.4. Copyright © 2013 World Gastroenterology Organization.
22. de Martel C, Parsonnet J.: Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci. 2006; 51: 2292-2301.
23. 13C-Urea breath test. BMC Public Health. 2013; 13: 1215.
24. Yu J, Liu S, Fang XC, et al.: Gastrointestinal symptoms and associated factors in Chinese patients with functional dyspepsia. World J Gastroenterol. 2013; 19: 5357-5364.
25. Labenz J, Rühl GH, Bertrams J, et al.: Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol. 1994; 89: 726-730. (Pubitemid 24132055)
26. Fuccio L, Zagari RM, Minardi ME, et al.: Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25: 133-141. (Pubitemid 46046370)